Navigation Links
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
Date:3/15/2011

meeting in January 2011.  Alexza anticipates resubmitting its AZ-004 NDA in July 2011.
  • Alexza announced that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).
  • Alexza received notice that AZ-004 is eligible for submission of a Marketing Authorization Application (MAA) under the centralized registration procedure.  Alexza has been notified of the Rapporteur and co-Rapporteur appointments for the AZ-004 review.  The Company believes that the comprehensive clinical development program for AZ-004 meets the requirements for the MAA filing and expects to submit the MAA in Q3 2011.

  • Financial Results - Periods Ended December 31, 2010 and 2009

    Alexza recorded $42.1 million and $42.9 million of revenues in the quarter and year ended December 31, 2010, and $9.5 million in the year ended December 31, 2009.  The Company recorded no revenues during the quarter ended December 31, 2009.  In October 2010, Biovail terminated the license and supply agreement for AZ-004, at which time Alexza recognized as revenue the $40 million non refundable up-front payment received in February 2010.  In September 2010, the Company began to recognize revenues related to payments received from Cypress Biosciences, Inc. as part of the license agreement signed in August 2010, resulting in revenues of $1.9 million and $2.6 million for the quarter and year ended December 31, 2010, respectively.  In January 2009, Alexza and Endo Pharmaceuticals mutually agreed to terminate their development agreement related to AZ-003 (Staccato fentanyl), at which time Alexza had fulfilled its obligations under the development agreement and recognized $9.5 million in revenues.

    GAAP
    '/>"/>

    SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
    2. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
    3. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
    4. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
    5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    6. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
    7. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    8. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
    9. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
    10. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
    11. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... April 24, 2015  Perrigo Company plc ("Perrigo" or ... of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: ... shares of Perrigo for $60.00 per share in cash ... share (the "Offer").  The Board previously ... significantly undervalued the Company and its future growth prospects ...
    (Date:4/24/2015)... April 24, 2015  New technologies and online ... to educate themselves about products and companies. Likewise, ... techniques available to market researchers seeking insights into ... marketplace, it,s imperative that organizations adjust their consumer ... market opportunities, niches and growth fronts. ...
    (Date:4/24/2015)... DUBLIN , Apr. 24, 2015 Research and ... addition of the "Global Biobanking Market 2015-2019" ... the Global Biobanking market to grow at a CAGR ... Global Biobanking market can be divided into two segments: ... and the growth prospects of the Global Biobanking market ...
    Breaking Medicine Technology:Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
    ... MUNDELEIN, Ill. , July 1 ... and information systems developer, today announces executive changes in ...  John Kershaw, President & CEO, Sysmex America Inc. has ... Secretary; Judy Bosko as Vice President of ...
    ... SCHAUMBURG, Ill. , July 1 ... today announced that the U.S. Food and Drug Administration ... sodium injection, USP. Heparin is a vital anticoagulant, preventing ... within the blood, routinely used in surgical and dialysis ...
    Cached Medicine Technology:Sysmex America Announces Executive Leadership Changes 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
    (Date:4/24/2015)... 2015 Ryadon is a leading manufacturer ... capabilities and services to complement any custom hardware requirements ... Program will be offered on all heavy duty drawer ... Receive 10% discount - Order 20+: Receive 20% discount ... Slides Products, Furniture ,Drawer ...
    (Date:4/24/2015)... The 1975 have had an intense past two ... theaters, festivals and TV performances. Now that they’ve settled back ... Dirty Hit Records, to provide clean drinking water to those ... Cadence & Cause website, this four-piece has graciously donated ... signed photo card. Entries from this sweepstakes will ...
    (Date:4/24/2015)... 24, 2015 Carinsurancequotesinfo.com has released a ... explaining how to qualify for auto insurance ... qualify for auto insurance online, without having to follow ... that single parents can reduce their auto insurance expenses. ... and properly explained. , Clients can now visit ...
    (Date:4/24/2015)... (PRWEB) April 24, 2015 “Kind,” “selfless,” ... were among the ways Denise Weiner described pediatric oncology ... cared for her daughter, Alexa, during her five-year battle ... resections, a bone marrow transplant and numerous experimental treatments, ... to visit Alexa when she was not in the ...
    (Date:4/24/2015)... 24, 2015 IntelliSoft Group, LLC, ... and contract management software, featured IntelliCred Version 14.2 ... Services Annual Educational Conference (IAMSS) on April ... Oak Brook, Illinois. , Notable improvements available in ... , Contract Linking: A new Contract ...
    Breaking Medicine News(10 mins):Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:IntelliSoft Group Version 14.2 of IntelliCred featured at the Illinois Association of Medical Staff Services Annual Educational Conference 2
    ... ... the latest technologies in Refractive and Corneal Surgery. , ... (Vocus) March 30, 2010 -- The Khanna Institute opens new office ... cities in the world. The city is known for its famous zip code, phenomenal shopping ...
    ... for this common condition, researchers say , TUESDAY, March 30 ... known as deep vein thrombosis, it is most likely to ... leg, Canadian researchers have found. , Dr. Wee-Shian Chan ... newly published review, said in a news release that the ...
    ... Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs ... symptoms of arthritis and other inflammatory disorders. But ... have osteoarthritis) these medications are also known to ... body, particularly in the gastrointestinal tract. ...
    ... that point to spectrum disorders , TUESDAY, March 30 ... brain proteins that seem to be linked to autism ... the most comprehensive genetic analyses of association between these ... disorder] risk," said Anthony Monaco, of the Wellcome Trust ...
    ... dying rose among older people cared for in minority ... many supportive relatives actually increases the fear of dying ... researchers. , The finding runs counter to the common ... the fear of death. It also has important implications ...
    ... has been thought that the loss of physical and psychological ... in brain structures. However, in the current edition of ... 107[12]: 199-205), Rainer Scheid and D. Yves von Cramon conclude ... brain injury is more frequent than stroke and is mostly ...
    Cached Medicine News:Health News:The Khanna Institute of LASIK and Refractive Surgery Opens New Office in Beverly Hills 2Health News:McMaster researcher leads development of promising drug for inflammation 2Health News:More Family Support Can Raise Fears For Some Elderly 2
    The rubber, whistle tip catheter with thumb valve has two side eyes to help minimize trauma....
    Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
    ... 8 Suction Catheters With Contro-Vac Valve and ... Low-Risk Respiratory Suctioning, ,Medline's 6 and ... DeLee Tips are the optimal tools for ... a forward placed suction valve to minimize ...
    ... available in two tip styles- ... with staggered eyes, and the ... of catheter valve options, SAFE-T-VAC ... control with virtually no residual ...
    Medicine Products: